Author | Katherine Mitchell, APRN, AOCNP

Articles

Treating Skin-Associated Toxicities Related to EGFR Inhibitors

January 20, 2017

In my practice, I am constantly being asked how to properly treat scalp involvement in relation to these skin toxicities.

Combating Rituximab-Induced Side Effects

December 14, 2016

I currently have a 77-year-old non-Hodgkin lymphoma patient that recently started bendamustine/rituximab combination therapy. After increasing the intravenous rituximab rate per protocol, she developed chills.

Narrowing Down the Options for Advanced Lung Cancer

October 24, 2016

I currently have a 68-year-old patient with EGFR-mutated adenocarcinoma of the lung, who presented with metastatic disease to the brain, liver, and bone in late 2014.

What Is Your Experience With Regorafenib?

September 16, 2016

If you’ve been in oncology long enough, you’ve likely seen the patient who presents with metastatic disease, gets first-line therapy, progresses, switches to second-line therapy, progresses again, and so on, with their cancer becoming increasingly more resistant to therapy.